Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters
Authors:
Open Access
- 28 October 2015
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 6, 1179
Abstract
An increase in the occurrence of potentially pathogenic Vibrio species is expected for waters in Northern Europe as a consequence of global warming. In this context, a higher incidence of Vibrio infections is predicted for the future and forecasts suggest that people visiting and living at the Baltic Sea are at particular risk. This study aimed to investigate antimicrobial resistance patterns among Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 isolates that could pose a public health risk. Antimicrobial susceptibility of 141 V. vulnificus and 184 V. cholerae non-O1/non-O139 strains isolated from German coastal waters (Baltic Sea and North Sea) as well as from patients and retail seafood was assessed by broth microdilution and disk diffusion. Both species were susceptible to most of the agents tested (12 subclasses) and no multidrug-resistance was observed. Among V. vulnificus isolates, non-susceptibility was exclusively found towards aminoglycosides. In case of V. cholerae, a noticeable proportion of strains was non-susceptible to aminopenicillins and aminoglycosides. In addition, resistance towards carbapenems, quinolones, and folate pathway inhibitors was sporadically observed. Biochemical testing indicated the production of carbapenemases with unusual substrate specificity in four environmental V. cholerae strains. Most antimicrobial agents recommended for treatment of V. vulnificus and V. cholerae non-O1/non-O139 infections were found to be effective in vitro. However, the occurrence of putative carbapenemase producing V. cholerae in German coastal waters is of concern and highlights the need for systematic monitoring of antimicrobial susceptibility in potentially pathogenic Vibrio spp. in Europe.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (VibrioNet 01KI1015A)
- Bundesinstitut für Risikobewertung (BfR 46-001)
This publication has 46 references indexed in Scilit:
- Genotypic Diversity and Virulence Characteristics of Clinical and Environmental Vibrio vulnificus Isolates from the Baltic Sea RegionApplied and Environmental Microbiology, 2013
- Molecular analysis of non-O1/non-O139 Vibrio choleraeisolated from hospitalised patients in ChinaBMC Microbiology, 2013
- Rapid Identification of Carbapenemase Types in Enterobacteriaceae and Pseudomonas spp. by Using a Biochemical TestAntimicrobial Agents and Chemotherapy, 2012
- Third-Generation Cephalosporin-ResistantVibrio cholerae, IndiaEmerging Infectious Diseases, 2012
- Multiple Antibiotic Resistance of Vibrio cholerae Serogroup O139 in China from 1993 to 2009PLOS ONE, 2012
- Carbapenem resistance in Enterobacteriaceae: here is the storm!Trends in Molecular Medicine, 2012
- Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence studyThe Lancet Infectious Diseases, 2011
- Antimicrobial Susceptibilities of Vibrio parahaemolyticus and Vibrio vulnificus Isolates from Louisiana Gulf and Retail Raw OystersApplied and Environmental Microbiology, 2007
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- Occurrence of Vibrio cholerae serogroups other than O1 and O139 in AustriaWiener klinische Wochenschrift, 2007